STAT Plus: Biotech 2020 preview: Takeover targets, notable drug launches, and genome editing readouts
Here's what to watch as the new year gets underway — some trends and burning questions about M&A, genome editing, and cell therapy.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario